Does IXEKIZUMAB Cause Angioedema? 89 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Angioedema have been filed in association with IXEKIZUMAB (TALTZ). This represents 0.3% of all adverse event reports for IXEKIZUMAB.
89
Reports of Angioedema with IXEKIZUMAB
0.3%
of all IXEKIZUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Angioedema From IXEKIZUMAB?
Of the 89 reports, 10 (11.2%) required hospitalization, and 3 (3.4%) were considered life-threatening.
Is Angioedema Listed in the Official Label?
Yes, Angioedema is listed as a known adverse reaction in the official FDA drug label for IXEKIZUMAB.
What Other Side Effects Does IXEKIZUMAB Cause?
Injection site pain (3,799)
Psoriasis (2,818)
Drug ineffective (2,759)
Injection site erythema (2,144)
Injection site reaction (1,701)
Injection site swelling (1,615)
Incorrect dose administered (1,032)
Covid-19 (861)
Product dose omission issue (832)
Therapy interrupted (796)
What Other Drugs Cause Angioedema?
LISINOPRIL (5,370)
IBUPROFEN (2,507)
OMALIZUMAB (1,650)
ACETAMINOPHEN (1,152)
RAMIPRIL (1,130)
AMOXICILLIN (943)
ASPIRIN (820)
CETIRIZINE (766)
DICLOFENAC (766)
SACUBITRIL\VALSARTAN (730)
Which IXEKIZUMAB Alternatives Have Lower Angioedema Risk?
IXEKIZUMAB vs JAKAFI
IXEKIZUMAB vs JANUMET
IXEKIZUMAB vs JANUVIA
IXEKIZUMAB vs JETREA
IXEKIZUMAB vs JUXTAPID